Donation Criteria
CWW will only consider applications from ministries of endemic countries. CWW’s Advisory Committee, an independent group of STH and global health experts, and the appropriate Regional Office of the World Health Organization (WHO) Neglected Tropical Disease (NTD) Department will evaluate all requests for donated ALB/MEB. Criteria for assessing requests include, but are not limited to:
- Burden of disease
- Previous experience implementing deworming activities
- Opportunities to integrate with other child health interventions
- Governmental support for deworming activities
- Additional criteria as described in the table below
Master Plans for Integrated Control of NTDs that have been approved by the Ministry of Health should be submitted along with the application form. If information requested in the application form is addressed in the Master Plan, please reference the requested information by providing on the form the specific section(s) and/or page numbers of the Master Plan.
Countries that are approved to receive donated drugs may be asked to provide additional information regarding drug management. Countries are asked to sign the Undertaking at the end of this application, which states that the countries will allow ALB/MEB to be imported without tax or duty, will distribute ALB/MEB for the purposes intended, will monitor for and report any serious adverse experiences, have secured resources for the effective and safe distribution of donated ALB/MEB, and will comply with reporting requirements. The donations are long-term provided that recipient countries meet the conditions outlined in the Undertaking. Countries will be asked to provide campaign results and submit a reapplication form to qualify for continued donation of medicines for MDAs.
| Criteria | Demonstrated by |
| High disease burden | Baseline intensity and prevalence surveys carried out in the last three years using guidelines of WHO |
| Resources committed by key stakeholders and funders, including the government |
Confirmed commitment from key stakeholder or funder, including the government Evidence of resources to implement a national STH control program, which includes distribution of ALB/MEB, training, social mobilization, and monitoring and evaluation activities |
| National ownership and commitment |
National Plan of Action for STH Control (criteria for acceptable plan of action to be established in collaboration with partners (e.g., WHO, USAID) Proportion of government resources (human and financial) committed to STH control |
| Partnerships for STH/NTD control |
National NTD Coordinating Committee that includes government ministries (e.g., MOH, MOE, Environment), NGOs, bilateral agencies, academia, and UN agencies NGOs should work in STH/NTD control |
| Safe and effective strategies for mass distribution | Evidence of capability to implement comparable MDA campaigns
Implementation strategies are outlined in Plan of Action High enrollment rate in primary schools and/or strategies for reaching out-of school children |
| Effective strategies for sustainability for STH control program |
WASH activities are included in Plan of Action Resources are secured for follow-up parasitological surveys % of population with access to water and sanitation facilities |
| Capacity to increase the scope of the STH control program as a result of receiving the donation |
Projected increase in the number of children to be treated Resources that would have been used for drug procurement are used to train teachers, and to carry out monitoring and evaluation activities |